Site icon pharmaceutical daily

The Pharmaceutical Industry in South Africa, 2019, with Comprehensive Profiles on 89 Companies – ResearchAndMarkets.com

BusinessWire

DUBLIN–(BUSINESS WIRE)–The “The
Pharmaceutical Industry in South Africa 2019” report has been
added to ResearchAndMarkets.com’s offering.

This report on the pharmaceutical industry describes the industry, its
size, new developments and factors influencing its success.

There are comprehensive profiles of 89 companies including the major
manufacturers Aspen Pharmacare, Adcock Ingram and Indian manufacturer
Cipla and the biggest retailers Dis-Chem and Clicks (New Clicks).

Other companies profiled include Ascendis Health, which has sold its
pharmaceutical manufacturing facility in Gauteng to Mylan for R130m and
is assessing the sale of other divisions and units to focus the business
and reduce debt.

The Pharmaceutical Industry

The pharmaceutical sector, which researches, develops, markets and
distributes drugs, as part of the wider healthcare system, is valued at
R50bn at manufacturers’ exit price and R68bn using retail sales.

The industry faces the challenge of expanding access to and
affordability of drugs, on the one hand and growing South Africa’s drug
manufacturing capacity on the other.

The sector seeks to meet this challenge in the context of implementation
of the National Health Insurance (NHI) and rapid technological
developments.

Changing Regulatory Environment

Several developments that will affect the industry include the Medical
Aid Schemes Bill, National Health Insurance Bill, intellectual property
regime overhaul, Competition Commission health inquiry and the
introduction of a new regulator for medicines, medical devices and
complementary medicines.

Following the legalisation of cannabis for private use, the first
medical cannabis cultivation licences have been awarded. All of these
issues are discussed in detail in the report.

Key Topics Covered

1. Introduction

2. Description of the Industry

2.1. Industry Supply Chain

2.2. Geographic Position

3. Size of the Industry

4. State of the Industry

4.1. Local

4.1.1. Corporate Actions

4.1.2. Regulations

4.1.3. Enterprise Development and Social Economic Development

4.2. Continental

4.3. International

5. Influencing Factors

5.1. Economic Environment

5.2. Labour Resources

5.3. Technology, Research and Development (R&D) and Innovation

5.4. Environmental Concerns

6. Competition

6.1. Barriers to Entry

7. SWOT Analysis

8. Outlook

9. Industry Associations

10. References

10.1. Publications

10.2. Websites

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/8wp4xr

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Pharmaceuticals

Exit mobile version